|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Abnormal liver enzymes: A review for clinicians显示文摘Liver biochemical tests are some of the most commonly ordered routine tests in the inpatient and outpatient setting,especially with the automatization of testing in this technological era.These tests include aminotransferases,alkaline phosphatase,gamma-glutamyl transferase,bilirubin,albumin,prothrombin time and international normalized ratio(INR).Abnormal liver biochemical tests can be categorized based on the pattern and the magnitude of aminotransferases elevation.Generally,abnormalities in aminotransferases can be classified into a hepatocellular pattern or cholestatic pattern and can be further sub-classified based on the magnitude of aminotransferase elevation to mild[<5×upper limit of normal(ULN)],moderate(>5-<15×ULN)and severe(>15×ULN).Hepatocellular pattern causes include but are not limited to;non-alcoholic fatty liver disease/non-alcoholic steatohepatitis,alcohol use,chronic viral hepatitis,liver cirrhosis(variable),autoimmune hepatitis,hemochromatosis,Wilson’s disease,alpha-1 antitrypsin deficiency,celiac disease,medication-induced and ischemic hepatitis.Cholestatic pattern causes include but is not limited to;biliary pathology(obstruction,autoimmune),other conditions with hyperbilirubinemia(conjugated and unconjugated).It is crucial to interpret these commonly ordered tests accurately as appropriate further workup,treatment and referral can greatly benefit the patient due to prompt treatment which can improve the natural history of several of the diseases mentioned and possibly reduce the risk of progression to the liver cirrhosis. | M Ammar Kalas Luis Chavez Monica Leon Pahnwat Tonya Taweesedt Salim Surani | 2021 | World Journal of Hepatology2021,13,11: | 5 |
| 2 | 用PDE-5抑制剂治疗勃起功能障碍的男性患者中前列腺癌的发生率:回顾性研究显示文摘本研究比较了用PDE-5抑制剂治疗勃起功能障碍(ED)7年的男性患者和与这些患者年龄及各种风险因素相似的7年内不使用PDE一5抑制剂治疗ED的男性患者中前列腺癌发生率的情况。通过分析2000年到2006年的电子病例和数据库,以年龄在50至69岁,2000年前无前列腺癌病史的ED患者作为研究对象。这些患者被分为两组:2362名曾用PDE-5抑制剂治疗的男性和2612名不曾使用过该药物的男性。比较每组的人口数据。在研究期内:97名(4.1%)接受过PDE-5抑制剂治疗的ED患者被诊断出患了前列腺癌,在非PDE-5抑制剂治疗组中,258名(9.9%)被诊断出患了前列腺癌(P〈O.0001)。在非洲裔美国人中,接受PDE-5抑制剂治疗的比例比不用的比例高(10.5%VS.7.1%,P〈0.0001)。接受过PDE-5治疗的患者,其前列腺特异性抗原增高的比例比较低(10.0%vs.13.1%,P=0.0008),但良性前列腺增生的比例比较高(38.4%vs.35.1%,P=0.0149)。接受PDE-5抑制剂治疗ED的男性不易患前列腺癌(调整后的优势比为0.4,95%CI:0.3—0.5,P〈0.0001)。我们的研究数据表明:用PDE-5抑制剂治疗ED的男性倾向于不易患前列腺癌。还需要进行更多的研究。 | Anthony H Chavez K Scott Coffield M Hasan Rajab Chanhee Joe | 2013 | Asian Journal of Andrology2013,15,2: | 2 |
| 3 | Determination of IgG subclasses and avidity of antithyroid peroxidase antibodies in patients with subclinical hypothyroidism-a comparison with patients with overt hypothyroidism显示文摘 | Silva L M Chavez J Canalli M H | 2003 | Horm Res2003,59,3: | 1 |
| 4 | Approximating probabilistie inference in Bayesian belief networks 显示文摘 | Dagum P Chavez R M | 1993 | IEEE Transactions on Pattern Analysis and Machine Intelligence1993,15,3: | 1 |
| 5 | Functional characterization of multiple domains in- volved in the subcellular localization of the hematopoi- etic Pbx interacting protein (HP1P) 显示文摘 | Abramovich C Chavez E A Lansdorp P M | 2002 | Oncogene2002,21,44: | 1 |
| 6 | Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer显示文摘 | Hernandez Aya L F Chavez Macgegor M Lei X | | 0,,19: | 1 |
| 7 | Internalization of SMmonellatyphimurium into mango pulp and pre- vention of fruit pulp contamination by chlorine and copper ions显示文摘 | Soto M Chavez G Baez M | 2007 | International Journal of En- vironmental Health Research2007,17,6: | 1 |
| 8 | Vascular complications of pancreatitis显示文摘More than 200000 hospital admissions happen per year for acute pancreatitis and more than 50000 for chronic pancreatitis in the United States of America.Necrotizing pancreatitis accounts for 20%-30%of the cases.One-quarter of the patients with pancreatitis develop vascular complications,which carries a high mortality.This mini-review will address these complications that can help primary care physicians and hospitalists in managing their patients effectively. | M Ammar Kalas Monica Leon Luis Omar Chavez Eduardo Canalizo Salim Surani | 2022 | World Journal of Clinical Cases2022,10,22: | 1 |
| 9 | 1,2,4,5-Tetrazine based energetic materials显示文摘 | Chavez D E Hiskey M A | 1999 | Journal of Energetic Materials1999,17,: | 1 |
| 10 | 3,3'-Azobis (6-amino-1,2,4,5-tetrazine) :A novel highnitrogen en- ergetic material 显示文摘 | Chavez D E Hiskey M A Gilardi R D | 2000 | Angew Chem2000,112,10: | 1 |
| 11 | Dynamic Granger-causal networks of electricity spot prices: A novel approach to market integration 显示文摘 | Castagneto-Gissey G Chavez M De Vico Fallani F | 2014 | Energy Economics2014,44,1: | 1 |
| 12 | Synthesis,characterization,and energetic properties of diazido heteroaromatic high-nitrogen C-N compound显示文摘 | Huynh M H V Hiskey M A Chavez D E | 2005 | J Am Chem Soc2005,127,12: | 1 |
| 13 | Variation in beliefs of college students about teaching cuhure 显示文摘 | Chavez M | 2005 | Die Unterrichtspraxis2005,38,1: | 1 |
| 14 | GS-9620,an oral agonist of Toll-like receptor-7,induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees显示文摘 | Lanford R E Guerra B Chavez D Frey C R Ohmstede C Hesselgesser J Kearney B Moorehead L Subramanian G M McHutchison J G | 2013 | Gastroenterology2013,144,7: | 1 |
| 15 | New high-nitrogen materials based on nitroguanyl-tetra-zines:Explosive properties,thermal decomposition and combustion studies显示文摘 | Chavez D E Tappan B C Hiskey M A | 2005 | Propellants Explosives Pyrotechnics2005,30,6: | 1 |
| 16 | Comparison of x-ray cross sec- tions for diagnostic and therapeutic medical physics 显示文摘 | Boone J M Chavez A E | 1996 | Medical Physics1996,23,12: | 1 |
| 17 | New high-nitrogen materials based on nitroguanyl-tetrazines:explosive properties,thermal decomposition and combustion studies显示文摘 | Chavez D E Tappan B C Hiskey M A | 2005 | Prop Expl Pyro2005,30,: | 1 |
| 18 | Circu-lating fibroblast growth factor-21 is elevated in impaired glucosetolerance and type 2 diabetes and correlates with muscle and hepat-ic insulin resistance 显示文摘 | Chavez AO Molina-Carrion M Abdul-G-hani MA | 2009 | Diabetes Care2009,32,8: | 1 |
| 19 | SAMe:S-Adenosylmethionine显示文摘 | Chavez M | 2000 | Am J Health Sys Pharm2000,57,: | 1 |
| 20 | 3,3'-Azobis(6-amino-1,2,4,5-tetrazine):A Novel High-Nitrogen Energetic Material显示文摘 | D E Chavez M A Hiskey R D Gilardi | 2000 | Angew Chem Int Ed Engl2000,39,: | 1 |